Future studies should examine the direct action of SGLT-2 inhibitors on atrial myocyte ion channels, particularly sodium, potassium, calcium, and calcium-activated non-selective cation channels, which have been implicated in AF remodeling [76]. This evidence concerns the gene SLC5A2 and atrial fibrillation.